Join
Live feed
·
INSIDERFilingvia Quantisnow
Zentalis Pharmaceuticals Inc. logo

Director Myers Scott Dunseth was granted 260,192 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ZNTL· Zentalis Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZNTL (Zentalis Pharmaceuticals Inc.) and more on Quantisnow.

Director Myers Scott Dunseth was granted 260,192 shares (SEC Form 4) | Quantisnow